Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients a double-masked, randomized, controlled trial.
J Am Coll Cardiol 2008; 51(22):2141-9JACC

Abstract

OBJECTIVES

Our goal was to test feasibility and efficacy of a dietary intervention based on daily intake of flavanol-containing cocoa for improving vascular function of medicated diabetic patients.

BACKGROUND

Even in fully medicated diabetic patients, overall prognosis is unfavorable due to deteriorated cardiovascular function. Based on epidemiological data, diets rich in flavanols are associated with a reduced cardiovascular risk.

METHODS

In a feasibility study with 10 diabetic patients, we assessed vascular function as flow-mediated dilation (FMD) of the brachial artery, plasma levels of flavanol metabolites, and tolerability after an acute, single-dose ingestion of cocoa, containing increasing concentrations of flavanols (75, 371, and 963 mg). In a subsequent efficacy study, changes in vascular function in 41 medicated diabetic patients were assessed after a 30-day, thrice-daily dietary intervention with either flavanol-rich cocoa (321 mg flavanols per dose) or a nutrient-matched control (25 mg flavanols per dose). Both studies were undertaken in a randomized, double-masked fashion. Primary and secondary outcome measures included changes in FMD and plasma flavanol metabolites, respectively.

RESULTS

A single ingestion of flavanol-containing cocoa was dose-dependently associated with significant acute increases in circulating flavanols and FMD (at 2 h: from 3.7 +/- 0.2% to 5.5 +/- 0.4%, p < 0.001). A 30-day, thrice-daily consumption of flavanol-containing cocoa increased baseline FMD by 30% (p < 0.0001), while acute increases of FMD upon ingestion of flavanol-containing cocoa continued to be manifest throughout the study. Treatment was well tolerated without evidence of tachyphylaxia. Endothelium-independent responses, blood pressure, heart rate, and glycemic control were unaffected.

CONCLUSIONS

Diets rich in flavanols reverse vascular dysfunction in diabetes, highlighting therapeutic potentials in cardiovascular disease.

Links

  • Publisher Full Text
    • Aggregator Full Text

    Authors+Show Affiliations

    Balzer J
    Department for Cardiology, Pulmonology, and Vascular Medicine, University Hospital RWTH Aachen, Aachen, Germany.
    Rassaf T
    No affiliation info available
    Heiss C
    No affiliation info available
    Kleinbongard P
    No affiliation info available
    Lauer T
    No affiliation info available
    Merx M
    No affiliation info available
    Heussen N
    No affiliation info available
    Gross HB
    No affiliation info available
    Keen CL
    No affiliation info available
    Schroeter H
    No affiliation info available
    Kelm M
    No affiliation info available

    MeSH

    AgedAged, 80 and overBrachial ArteryCacaoCardiovascular DiseasesCross-Over StudiesDiabetes Mellitus, Type 2Double-Blind MethodEndothelium, VascularFeasibility StudiesFemaleFlavonolsHumansMaleMiddle AgedPrognosisRisk FactorsTime Factors

    Pub Type(s)

    Clinical Trial
    Journal Article
    Randomized Controlled Trial
    Research Support, Non-U.S. Gov't

    Language

    eng

    PubMed ID

    18510961